Detectable TFAP2D expression was strongly linked to outcome in ERG negative cancers (p < 0.0001, Fig. 3b) but completely unrelated to patient outcome in ERG positive cancers (p = 0.9543, Fig. 3c). The gene discussed is TFAP2D; the disease is cancer.